Tyrosine
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
4927 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Non-small-cell lung carcinoma | D002289 | — | — | 267 | 558 | 193 | 31 | 131 | 1056 |
| Lung neoplasms | D008175 | HP_0100526 | C34.90 | 212 | 465 | 136 | 15 | 94 | 820 |
| Leukemia | D007938 | — | C95 | 221 | 431 | 121 | 31 | 116 | 808 |
| Neoplasms | D009369 | — | C80 | 309 | 215 | 20 | 6 | 41 | 515 |
| Myeloid leukemia | D007951 | — | C92 | 130 | 229 | 63 | 25 | 82 | 464 |
| Lymphoma | D008223 | — | C85.9 | 156 | 294 | 44 | 8 | 17 | 447 |
| Bcr-abl positive chronic myelogenous leukemia | D015464 | EFO_0000340 | — | 82 | 198 | 60 | 31 | 83 | 414 |
| Breast neoplasms | D001943 | EFO_0003869 | C50 | 109 | 236 | 38 | 1 | 18 | 360 |
| Lymphoid leukemia | D007945 | — | C91 | 101 | 208 | 51 | 6 | 34 | 352 |
| Carcinoma | D002277 | — | C80.0 | 112 | 206 | 34 | 2 | 37 | 340 |
Show 46 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Recurrence | D012008 | — | — | 77 | 133 | 2 | — | 3 | 184 |
| Myeloid leukemia acute | D015470 | — | C92.0 | 69 | 74 | 13 | — | 19 | 138 |
| Neoplasm metastasis | D009362 | EFO_0009708 | — | 35 | 72 | 16 | — | 12 | 121 |
| Brain neoplasms | D001932 | EFO_0003833 | C71 | 29 | 67 | 14 | — | 10 | 109 |
| Head and neck neoplasms | D006258 | — | — | 34 | 58 | 10 | — | 4 | 96 |
| Colorectal neoplasms | D015179 | — | — | 44 | 63 | 5 | — | 6 | 94 |
| Liver neoplasms | D008113 | EFO_1001513 | C22.0 | 27 | 49 | 10 | — | 11 | 83 |
| Glioblastoma | D005909 | EFO_0000515 | — | 36 | 55 | 1 | — | 4 | 80 |
| Hepatocellular carcinoma | D006528 | — | C22.0 | 24 | 45 | 8 | — | 15 | 79 |
| Ovarian neoplasms | D010051 | EFO_0003893 | C56 | 21 | 46 | 5 | — | 1 | 62 |
Show 120 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Healthy volunteers/patients | — | — | — | 139 | 5 | — | — | 4 | 148 |
| Glioma | D005910 | EFO_0000520 | — | 27 | 27 | — | — | 7 | 52 |
| Gliosarcoma | D018316 | — | — | 13 | 21 | — | — | — | 28 |
| Nervous system neoplasms | D009423 | — | — | 17 | 17 | — | — | 3 | 28 |
| Cholangiocarcinoma | D018281 | — | C22.1 | 10 | 18 | — | — | 1 | 26 |
| Colonic neoplasms | D003110 | — | C18 | 14 | 13 | — | — | — | 22 |
| Nasopharyngeal carcinoma | D000077274 | — | — | 9 | 16 | — | — | 1 | 20 |
| Salivary gland neoplasms | D012468 | EFO_0003826 | D11 | 7 | 13 | — | — | 1 | 19 |
| Skin neoplasms | D012878 | EFO_0004198 | C44 | 7 | 14 | — | — | — | 18 |
| Laryngeal neoplasms | D007822 | EFO_0003817 | C32 | 10 | 12 | — | — | 1 | 18 |
Show 347 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Hepatic insufficiency | D048550 | — | — | 12 | — | — | — | 1 | 13 |
| Renal insufficiency | D051437 | HP_0000083 | N19 | 7 | — | — | — | 1 | 8 |
| Pharmacokinetics | D010599 | — | — | 5 | — | — | — | 1 | 6 |
| Liver failure | D017093 | HP_0001399 | K72.9 | 5 | — | — | — | 1 | 6 |
| Oncogenes | D009857 | — | — | 4 | — | — | — | — | 4 |
| Drug interactions | D004347 | — | — | 4 | — | — | — | — | 4 |
| Medullary carcinoma | D018276 | — | — | 1 | — | — | — | 2 | 3 |
| Mycoses | D009181 | — | B35-B49 | 3 | — | — | — | — | 3 |
| Mycosis fungoides | D009182 | — | C84.0 | 3 | — | — | — | — | 3 |
| Plasmablastic lymphoma | D000069293 | — | C83.3 | 3 | — | — | — | — | 3 |
Show 70 more
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Atrial fibrillation | D001281 | EFO_0000275 | I48.0 | — | — | — | — | 6 | 6 |
| Chronic obstructive pulmonary disease | D029424 | EFO_0000341 | J44.9 | — | — | — | — | 5 | 5 |
| Fatigue | D005221 | HP_0012378 | R53.83 | — | — | — | — | 4 | 4 |
| Pregnancy-induced hypertension | D046110 | — | O13 | — | — | — | — | 3 | 3 |
| Diet therapy | D004035 | — | — | — | — | — | — | 2 | 2 |
| Muscular atrophy | D009133 | HP_0003202 | — | — | — | — | — | 2 | 2 |
| Protein deficiency | D011488 | — | — | — | — | — | — | 2 | 2 |
| Sensitivity training groups | D012681 | — | — | — | — | — | — | 2 | 2 |
| Premature birth | D047928 | EFO_0003917 | O60 | — | — | — | — | 2 | 2 |
| Obstructive lung diseases | D008173 | HP_0006536 | — | — | — | — | — | 2 | 2 |
Show 102 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
No data
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
345 adverse events reported
View more details
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use